{
  "guideline_id": "I.C.2.s",
  "semantic_title": "Coding Guidelines for Breast Implant Associated Anaplastic Large Cell Lymphoma",
  "section_path": "Section I > C. Chapter-Specific Coding Guidelines > 2. Chapter 2: Neoplasms > s. Breast Implant Associated Anaplastic Large Cell Lymphoma",
  "page_number": 39,
  "content": {
    "full_text": "Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is a type of lymphoma that can develop around breast implants. Assign code C84.7A, Anaplastic large cell lymphoma, ALK-negative, breast, for BIA-ALCL or C84.7B, Anaplastic large cell lymphoma, ALK-negative, in remission, for BIA-ALCL in remission. Do not assign a complication code from chapter 19. (Evidence: pg no: 39, L77-L80)",
    "summary": "Specific coding guidelines for breast implant associated anaplastic large cell lymphoma (BIA-ALCL) (Evidence: pg no: 39, L77-L80)",
    "key_concepts": [
      "BIA-ALCL is lymphoma that develops around breast implants (Evidence: pg no: 39, L77-L78)",
      "Use C84.7A for active BIA-ALCL (Evidence: pg no: 39, L78-L79)",
      "Use C84.7B for BIA-ALCL in remission (Evidence: pg no: 39, L79-L80)",
      "Do not use Chapter 19 complication codes (Evidence: pg no: 39, L80)"
    ],
    "detailed_rules": [
      {
        "rule_id": "bia_alcl_definition",
        "rule_text": "BIA-ALCL is a type of lymphoma that can develop around breast implants (Evidence: pg no: 39, L77-L78)",
        "explanation": "This is a specific type of lymphoma with a known association to breast implants, requiring specific coding (Evidence: pg no: 39, L77-L78)",
        "importance": "high",
        "applies_to": "breast implant associated lymphomas",
        "common_applications": [
          "Lymphoma diagnosed around breast implants",
          "Post-implant lymphoproliferative disorders"
        ]
      },
      {
        "rule_id": "active_bia_alcl_coding",
        "rule_text": "Assign code C84.7A for BIA-ALCL (Evidence: pg no: 39, L78-L79)",
        "explanation": "C84.7A is the specific code for active breast implant associated anaplastic large cell lymphoma (Evidence: pg no: 39, L78-L79)",
        "importance": "critical",
        "applies_to": "active BIA-ALCL cases",
        "common_applications": [
          "Newly diagnosed BIA-ALCL",
          "Active treatment of BIA-ALCL"
        ]
      },
      {
        "rule_id": "remission_bia_alcl_coding",
        "rule_text": "Assign code C84.7B for BIA-ALCL in remission (Evidence: pg no: 39, L79-L80)",
        "explanation": "C84.7B is specifically for BIA-ALCL that has achieved remission status (Evidence: pg no: 39, L79-L80)",
        "importance": "critical",
        "applies_to": "BIA-ALCL in remission",
        "common_applications": [
          "Follow-up visits for treated BIA-ALCL",
          "Surveillance of BIA-ALCL in remission"
        ]
      },
      {
        "rule_id": "no_complication_codes",
        "rule_text": "Do not assign a complication code from chapter 19 (Evidence: pg no: 39, L80)",
        "explanation": "BIA-ALCL should not be coded as a device complication but as a specific lymphoma (Evidence: pg no: 39, L80)",
        "importance": "critical",
        "applies_to": "all BIA-ALCL cases",
        "common_applications": [
          "Avoiding T85.- codes for BIA-ALCL",
          "Not using breast implant complication codes"
        ]
      }
    ],
    "workflow_steps": [
      "Step 1: Identify anaplastic large cell lymphoma associated with breast implants",
      "Step 2: Determine if lymphoma is active or in remission",
      "Step 3a: If active - assign C84.7A",
      "Step 3b: If in remission - assign C84.7B",
      "Step 4: Do not add Chapter 19 complication codes"
    ],
    "related_terminology": [
      "Breast implant associated anaplastic large cell lymphoma",
      "BIA-ALCL",
      "ALK-negative lymphoma",
      "Breast implants",
      "Anaplastic large cell lymphoma"
    ]
  },
  "code_references": {
    "code_ranges": [],
    "specific_codes": [
      {
        "code": "C84.7A",
        "description": "Anaplastic large cell lymphoma, ALK-negative, breast (Evidence: pg no: 39, L78-L79)",
        "context": "Used for active BIA-ALCL",
        "requires_additional_codes": false,
        "breakdown": {
          "C84": "Mature T/NK-cell lymphomas",
          "7A": "Anaplastic large cell lymphoma, ALK-negative, breast"
        }
      },
      {
        "code": "C84.7B",
        "description": "Anaplastic large cell lymphoma, ALK-negative, in remission (Evidence: pg no: 39, L79-L80)",
        "context": "Used for BIA-ALCL in remission",
        "requires_additional_codes": false,
        "breakdown": {
          "C84": "Mature T/NK-cell lymphomas",
          "7B": "Anaplastic large cell lymphoma, ALK-negative, in remission"
        }
      }
    ],
    "code_patterns": [],
    "code_categories_mentioned": [
      "Lymphoma codes",
      "Chapter 19 complication codes (excluded)"
    ]
  },
  "cross_references": {
    "references_to": [],
    "referenced_by": []
  },
  "coding_scenarios": [
    {
      "scenario_id": "active_bia_alcl",
      "scenario": "Patient diagnosed with breast implant associated anaplastic large cell lymphoma",
      "documentation_example": "Newly diagnosed BIA-ALCL (breast implant associated anaplastic large cell lymphoma) around left breast implant",
      "step_by_step": [
        "Step 1: Identify BIA-ALCL diagnosis",
        "Step 2: Determine lymphoma is active (newly diagnosed)",
        "Step 3: Assign C84.7A",
        "Step 4: Do not add complication codes"
      ],
      "correct_coding": {
        "primary_code": "C84.7A (Anaplastic large cell lymphoma, ALK-negative, breast)",
        "secondary_codes": [],
        "sequencing": "BIA-ALCL code only",
        "rationale": "Active BIA-ALCL uses C84.7A without complication codes (Evidence: pg no: 39, L78-L80)"
      },
      "incorrect_coding": {
        "code": "T85.79XA",
        "codes": [
          "T85.79XA (Other specified complications of other internal prosthetic devices, implants and grafts)"
        ],
        "rationale": "Should not use Chapter 19 complication codes for BIA-ALCL",
        "common_mistake": "Coding as device complication instead of specific lymphoma"
      }
    },
    {
      "scenario_id": "bia_alcl_remission",
      "scenario": "Patient with history of BIA-ALCL, currently in remission after treatment",
      "documentation_example": "Follow-up visit for BIA-ALCL, currently in complete remission following treatment",
      "step_by_step": [
        "Step 1: Identify BIA-ALCL history",
        "Step 2: Determine lymphoma is in remission",
        "Step 3: Assign C84.7B",
        "Step 4: Do not add complication codes"
      ],
      "correct_coding": {
        "primary_code": "C84.7B (Anaplastic large cell lymphoma, ALK-negative, in remission)",
        "secondary_codes": [],
        "sequencing": "BIA-ALCL remission code only",
        "rationale": "BIA-ALCL in remission uses C84.7B (Evidence: pg no: 39, L79-L80)"
      },
      "incorrect_coding": {
        "code": "Z85.79",
        "codes": [
          "Z85.79 (Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues)"
        ],
        "rationale": "Should use specific remission code rather than personal history",
        "common_mistake": "Using personal history instead of remission code"
      }
    }
  ],
  "procedure_links": [],
  "examples": [],
  "special_notes": {
    "warnings": [
      "Never use Chapter 19 complication codes for BIA-ALCL (Evidence: pg no: 39, L80)"
    ],
    "best_practices": [
      "Use specific BIA-ALCL codes C84.7A or C84.7B (Evidence: pg no: 39, L78-L80)",
      "Determine remission status for appropriate code selection (Evidence: pg no: 39, L78-L80)"
    ],
    "common_mistakes": [
      "Coding as device complication instead of specific lymphoma (Evidence: pg no: 39, L80)",
      "Using wrong code for remission status"
    ],
    "tips": [
      "BIA-ALCL has specific codes separate from device complications (Evidence: pg no: 39, L78-L80)",
      "Remission status determines code choice (Evidence: pg no: 39, L78-L80)"
    ],
    "implementation_notes": [],
    "clinical_context": [
      "Applies to lymphomas specifically associated with breast implants"
    ]
  },
  "search_keywords": [
    "BIA-ALCL",
    "breast implant",
    "anaplastic large cell lymphoma",
    "C84.7A",
    "C84.7B",
    "ALK-negative",
    "breast lymphoma"
  ],
  "metadata": {
    "category": "chapter_specific",
    "subcategory": "specific_lymphoma",
    "complexity_level": "intermediate",
    "applies_to_settings": [
      "inpatient",
      "outpatient"
    ],
    "last_updated": "FY 2026",
    "tags": [
      "BIA-ALCL",
      "breast_implant",
      "lymphoma",
      "specific_codes"
    ]
  },
  "page_range_processed": "pages_36_to_39"
}